DrugPatentWatch Database Preview
Drugs in Development Information for Molidustat
Drug Development Status for Molidustat: Sponsors, patents, clinical trial progress
Molidustat is an investigational drug.
There have been 9 clinical trials for Molidustat.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 30th 2017.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are eight US patents protecting this investigational drug and one hundred and seventy-four international patents.
Summary for Molidustat
| US Patents | 8 |
| International Patents | 174 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 7 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-11-30) |
| Vendors | 38 |
Recent Clinical Trials for Molidustat
| Title | Sponsor | Phase |
|---|---|---|
| Maintenance Treatment of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
Clinical Trial Summary for Molidustat
Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat
US Patents for Molidustat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Molidustat | Start Trial | Method for the preparation of triazole compounds | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | Start Trial |
| Molidustat | Start Trial | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| Molidustat | Start Trial | Substituted sodium 1H-pyrazol-5-olate | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| Molidustat | Start Trial | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| Molidustat | Start Trial | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| Molidustat | Start Trial | Substituted dihydropyrazolones for treating cardiovascular and hematological diseases | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| Molidustat | Start Trial | Substituted sodium-1H-pyrazole-5-olate | Bayer Intellectual Property GmbH (Monheim, DE) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Molidustat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Molidustat | Australia | 2013258107 | 2032-05-08 | Start Trial |
| Molidustat | Canada | 2872726 | 2032-05-08 | Start Trial |
| Molidustat | Chile | 2014003003 | 2032-05-08 | Start Trial |
| Molidustat | Chile | 2016001165 | 2032-05-08 | Start Trial |
| Molidustat | China | 104411704 | 2032-05-08 | Start Trial |
| Molidustat | Colombia | 7121324 | 2032-05-08 | Start Trial |
| Molidustat | Costa Rica | 20140514 | 2032-05-08 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
